|
COMMERCE BUSINESS DAILY ISSUE OF JANUARY 26,1995 PSA#1270NON-INVASIVE BIOMEDICAL INSTRUMENTATION OPPORTUNITIES POC: NASA Langley
Research Center, Industry Assistance Office, Mailstop 144, Hampton, VA
23681-0001. In order that potential participants may learn of
non-invasive biomedical instrumentation opportunities, an advanced
notice is published here. Five medical device technologies resulting
from NASA Langley Research Center's expertise in instrumentation design
and development and nondestructive measurement science are available
for joint development activities and licensing. A method to measure the
thickness of the diaphragm in real time with an ultrasonic device and
display variations in diaphragm thickness versus time is realized by a
non-invasive evaluation of diaphragm function technology (Patent
Application #8/195,500). By having a patient attempt to maintain a
constant breathing pattern against two different pressures, one can
calculate a quantitative value for the reserve fatigue capacity of the
diaphragm. Information about pressure ulcers is provided by a
ultrasonic system that discriminates between healthy versus necrotic
tissue in the region of existing or incipient pressure ulcers. This
technology offers the potential for a non-invasive monitoring method to
detect pressure ulcer formation while still reversible. It also may be
used to discriminate that margins of degenerative tissue in a erupted
pressure sore. The intracranial pressure measurement (Patent
Application #8/297,474) technology consists of an ultrasonic instrument
for the indirect measurement of intracranial pressure (ICP) and a
calibration procedure to determine absolute values of ICP and pressure
volume index. Remote monitoring of ICP reduces the risk of infection
from in-dwelling transcranial probes or pressure catheters. A prototype
circumferential pressure probe (Patent #4,873,990) has been developed
and tested for urodynamic pressure measurement in the bladder and at
several points along the urethra in the region of the sphincter muscle.
The probe consists of a flexible catheter with a central lumen for
fluid insertion/withdrawal. The sensing region of the catheter contains
a series of strain gauge sensors designed to measure true
circumferential pressure rather than pressure at an isolated
``window''. The fifth medical technology consists of a new x-ray
detector for use in digital mammography, consisting of a mosaic of
commercially available CCD arrays that provide the advantages of
digital detection in a large format array. The large field of view and
high sensitivity enable this device to potentially be used for
screening mammography, providing enhanced detection of early breast
cancer which is characterized by small and potentially obscure features
of interest. This notice announces NASA's interest and desire to enter
a joint development and commercialization agreement with private
industry to advance the development and testing of these technologies,
and to transfer NASA's existing proprietary technology(s) and that
resulting from joint work under the development agreements(s) by making
it available for license to the joint participants(s) in accordance
with NASA's Patent Licensing Regulations. Accordingly, a technical
briefing will be held in mid March 1995 at NASA Langley Research
Center, Hampton, VA 23681-0001 to describe the technology, outline the
planned Space Act agreement, and explain the process and criteria
under which NASA will select a participant(s). Interested organizations
should submit an expression of interest and a statement of
qualification, including: technical experience and competence in the
technologies of interest, related manufacturing capabilities,
experience in commercializing similar products, marketing organization
(including resources and capabilities to reach and support targeted
markets), and financial status of the firm. This synopsis is for
information and planning purposes only and is not to be construed as a
commitment by NASA nor will NASA pay for the information solicited.
Respondents will not automatically be notified of the results of the
evaluation, but those deemed fully qualified will be considered in any
resulting requirement. This is not an announcement of an RFP.
Expressions of interest should be submitted by February 10, 1995.
Requests for additional information should be directed to Dr. Frank
Farmer, (804)864-2490 or Marisol Romero (804)864-5355. Loren Data Corp. http://www.ld.com (SYN# 0629 19950125\SP-0001.MSC)
SP - Special Notices Index Page
|
|